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ABSTRACT This is a report of the complete genome sequences of plaque-selected
isolates of five virus strains included in bottle A of the South African Onderstepoort
Biological Products commercial live attenuated bluetongue virus vaccine.
Bluetongue is an arthropod-borne disease of domestic ruminants, certain wildungulates, and camelids which is caused by the bluetongue virus (BTV; genus
Orbivirus, family Reoviridae). The BTV genome is composed of 10 segments of double-
stranded RNA that cumulatively encode 7 structural (VP1 to VP7) and 4 nonstructural
(NS1 to NS4) proteins. Segment 2 of the viral genome is highly variable and encodes the
outer coat protein VP2. Currently, 28 distinct serotypes of the virus have been identified
based on the interaction of the VP2 protein and neutralizing antibodies that are
produced by the host immune system (1). Bluetongue virus is endemic in South Africa,
with most of the described serotypes having been isolated from this country. To protect
against circulating serotypes, a live pentavalent vaccine consisting of 3 bottles, each
containing 5 serotypes per bottle (bottle A, serotypes 1, 4, 6, 12, and 14; bottle B,
serotypes 3, 8, 9, 10, and 11; bottle C, serotypes 2, 5, 7, 13, and 17), is produced by
Onderstepoort Biological Products (OBP; product no. 2013; registration no. G 0358 [Act
36/1947]) (2). We previously reported the full-genome sequences of the plaque-purified
strains contained in bottle C of the OBP vaccine (3). Here, we report the genome
sequences of the plaque-purified strains of bottle A of the OBP vaccine.
The serotypes were isolated from bottle A (OBP batch no. 115; expiration date,
11 October 2015) using plaque selection on Vero cells as previously described (4). Prior
to RNA extraction, the plaque-selected viruses were propagated for 1 round on Vero
cells (25 cm2), and the cells were harvested when the cytopathic effect was advanced.
Total RNA was extracted from the infected cell pellets using TRIzol (Invitrogen),
according to the manufacturer’s instructions. Single-stranded RNA (ssRNA) was subse-
quently precipitated from the total RNA using LiCl precipitation (2 M final concentra-
tion) and collected by centrifugation. The double-stranded RNA (dsRNA) remaining in
the supernatant was purified through a QIAquick PCR purification column (Qiagen), and
the eluted dsRNA was assessed for concentration and purity using a NanoDrop instru-
ment (Thermo Scientific). The purified dsRNA was amplified using the sequence-
independent amplification method described by Potgieter et al. (5). The method
involves the ligation of scorpion primers to the ends of the viral genome segments,
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followed by the conversion of denatured dsRNA to DNA using reverse transcription. The
genome is then amplified using primers that are complementary to regions on the
ligated scorpion primers (5).
Full-genome amplicons were sequenced on a Sequel instrument (Pacific Biosciences
[PacBio], Menlo Park, CA, USA) using a commercial service provider (Sequencing Core
Facility, National Institute for Communicable Diseases, Sandringham, Johannesburg,
South Africa). Briefly, the sequence library was prepared by subjecting PCR-amplified
genomes to the PacBio protocol for preparing multiplexed microbial SMRTbell libraries
(“Preparing multiplexed microbial libraries using SMRTbell Express template prep kit
2.0”) but without DNA shearing. The library was subsequently sequenced as a pooled
equimolar 8-plex library, with an on-plate concentration of 4 pM DNA. Data were
recorded using a 10-h movie time and v3.0 chemistry; Sequel Polymerase v3.0 and
single-molecule real-time (SMRT) cells v3 were used. Circular consensus sequencing
(CCS) analysis was performed using the PacBio SMRT link v6 software, using default
parameters.
High-quality CCS (Q20) reads were generated for all five genomes and ranged from
21,257 to 31,452 reads per genome, with the mean read lengths ranging from 1,711 to
2,161 bp. The final genome sequences were generated from the CCS reads by mapping
the data to sequences of South African reference strains of BTV that are available in
GenBank, using Geneious Prime v2020.1.1. Consensus sequences were next generated
from the mapped CCS reads by majority vote, and the genome segments were trimmed
so that they were of the same length as the reference genome segments to which the
CCS reads were mapped. In order to ensure that we reported full-length genome
nucleotide sequences that included 5=- and 3=-untranslated-region (UTR) sequences, we
manually confirmed the presence of terminal conserved hexanucleotide sequences (5=
[GTTAAA] and 3= [ACTTAC]) that have previously been described as being present on
the ends of BTV genome segments (6). The assembled genome segments and the
raw sequence reads (FASTQ files) have been submitted to GenBank (accession no.
PRJNA401524), with the relevant accession numbers being provided in Table 1.
The newly sequenced vaccine strains were compared against previously sequenced
reference strains of BTV (Howell reference strains, Agricultural Research Council—
Onderstepoort Veterinary Research Institute [ARC-OVR]), as well as OBP BTV vaccine
strains that were sequenced in other studies. Multiple sequence alignments (MUSCLE)
and pairwise sequence comparisons were conducted using Geneious Prime v2020.1.1.
In general, we found high nucleotide sequence identity between the genomes that
were sequenced in this study and previously published OBP BTV vaccine strains and
ARC-OVR reference strains that are available in GenBank. The genome of BTV-1 was
99.98% identical to an independently sequenced BTV-1 vaccine strain (RSAvvvv/01;
GenBank accession no. KP820897, KP821017, KP821139, KP821259, KP821379,
KP821499, KP821621, KP821741, KP821862, and KP821982) and 99.91% identical to the
ARC-OVR reference strain of BTV-1 (BTV-1 isolate 5012; accession no. JX272379 through
JX272388). The BTV-4 genome was 99.97% identical to a previously sequenced BTV-4
vaccine strain [BTV4-RSA(vacc); accession no. JN255942 through JN255951] and 99.86%
identical to the ARC-OVR reference strain of BTV-4 (BTV-4 isolate 79043; accession
no. JX272579 through JX272588). The BTV-6 vaccine strain shared 99.98% identity with
a previously published BTV-6 vaccine strain (BTV-6 5011-60E; accession no. GQ506506
through GQ506515) and 99.84% identity to the ARC-OVR reference strain










(%)VP1 VP2 VP3 VP4 VP5 VP6 VP7 NS1 NS2 NS3
BTV-1 19,430 MT070929 MT070930 MT070931 MT070932 MT070934 MT070937 MT070935 MT070933 MT070936 MT070938 SRR11413045 44.0
BTV-4 19,442 MT070919 MT070920 MT070921 MT070922 MT070924 MT070927 MT070925 MT070923 MT070926 MT070928 SRR11413044 44.2
BTV-6 19,414 MT070909 MT070910 MT070911 MT070912 MT070914 MT070917 MT070915 MT070913 MT070916 MT070918 SRR11413043 44.0
BTV-12 19,404 MT070899 MT070900 MT070901 MT070902 MT070904 MT070907 MT070905 MT070903 MT070906 MT070908 SRR11413042 44.0
BTV-14 19,414 MT070889 MT070890 MT070891 MT070892 MT070894 MT070897 MT070895 MT070893 MT070896 MT070898 SRR11413041 44.2
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of BTV-6 (BTV-6 RSArrrr/06; accession no. GQ506498 through GQ506505, AJ585127, and
AJ586703). The BTV-12 strain was 99.86% identical to the ARC-OVR BTV-12 reference
strain (BTV-12 isolate 75005; accession no. JX272499 through JX272508), whereas
BTV-14 shared 99.84% identity with the ARC-OVR BTV-14 reference strain (BTV-14
isolate BT87/59; accession no. JX272479 through JX272488).
The use of the OBP live attenuated BTV vaccine has been associated with the spread
of the vaccine viruses in the field and the exchange of genetic material between
wild-type and vaccine strains through genetic reassortment and intragenic recombi-
nation. It has been suggested that the exchange of genetic material between vaccine
and wild-type viruses may potentially confer a fitness advantage to progeny virions (7,
8). It is therefore of interest to trace the spread of the OBP vaccine strains and their
genome segments in the field. The availability of authentic full-genome sequence data
of strains that are included in bottle A of the OBP BTV vaccine currently being sold will
assist with tracking the spread of the constituent strains in the field.
Data availability. The accession numbers for the assembled genome segments and
their associated raw sequence reads (SRA accession numbers) are provided in Table 1.
ACKNOWLEDGMENTS
This work was supported by funds provided by South African funding agencies, i.e.,
the University of Pretoria, the National Research Foundation (NRF), the Meat Industry
Trust (MIT), and the Technology Innovation Agency (TIA). Funding for publication was
provided by the Department of Pathology, Microbiology, and Immunology (UC Davis).
REFERENCES
1. Bumbarov V, Golender N, Jenckel M, Wernike K, Beer M, Khinich E, Zalesky
O, Erster O. 2020. Characterization of bluetongue virus serotype 28.
Transbound Emerg Dis 67:171–182. https://doi.org/10.1111/tbed.13338.
2. Coetzee P, Stokstad M, Venter EH, Myrmel M, Van Vuuren M. 2012.
Bluetongue: a historical and epidemiological perspective with the em-
phasis on South Africa. Virol J 9:198. https://doi.org/10.1186/1743-422X
-9-198.
3. van den Bergh C, Coetzee P, Guthrie AJ, le Grange M, Venter EH. 2016.
Complete genome sequences of five bluetongue virus (BTV) vaccine
strains from a commercial live attenuated vaccine, a BTV-4 field strain
from South Africa, and a reassortant strain isolated from experimentally
vaccinated cattle. Genome Announc 4:e00462-16. https://doi.org/10
.1128/genomeA.00462-16.
4. Howell PG, Kümm NA, Botha MJ. 1970. The application of improved
techniques to the identification of strains of bluetongue virus. Onder-
stepoort J Vet Res 37:59 – 66.
5. Potgieter AC, Page NA, Liebenberg J, Wright IM, Landt O, van Dijk AA.
2009. Improved strategies for sequence-independent amplification and
sequencing of viral double-stranded RNA genomes. J Gen Virol 90:
1423–1432. https://doi.org/10.1099/vir.0.009381-0.
6. Attoui H, Mertens PPC, Becnel J, Belaganahalli S, Bergoin M, Brussaard CP,
Chappell JD, Ciarlet M, del Vas M, Dermody TS. 2011. The double stranded
RNA viruses—Orbivirus, Reoviridae, p 592– 603. In King AMQ, Adams MJ,
Carstens EB, Lefkowitz EJ (ed), Virus taxonomy: ninth report of the Inter-
national Committee on Taxonomy of Viruses. Elsevier Academic Press, San
Diego, CA.
7. He C-Q, Ding N-Z, He M, Li S-N, Wang X-M, He H-B, Liu X-F, Guo H-S.
2010. Intragenic recombination as a mechanism of genetic diversity in
bluetongue virus. J Virol 84:11487–11495. https://doi.org/10.1128/JVI
.00889-10.
8. Nomikou K, Hughes J, Wash R, Kellam P, Breard E, Zientara S, Palmarini M,
Biek R, Mertens P. 2015. Widespread reassortment shapes the evolution
and epidemiology of bluetongue virus following European invasion. PLoS
Pathog 11:e1005056. https://doi.org/10.1371/journal.ppat.1005056.
Microbiology Resource Announcement
Volume 9 Issue 22 e00310-20 mra.asm.org 3
 on A
pril 26, 2021 at JA
M
E
S
 C
O
O
K
 U
N
IV
E
R
S
IT
Y
http://m
ra.asm
.org/
D
ow
nloaded from
 
